Michel Roberge

Screen for Chemical Modulators of Autophagy Reveals Novel Therapeutic Inhibitors of mTORC1 Signaling

Aruna D. Balgi, Bruno D. Fonseca, Elizabeth Donohue et al. · PLoS ONE · 2009 · 344 citations · Full text

Phase I Trial of 72-Hour Continuous Infusion UCN-01 in Patients With Refractory Neoplasms

Edward A. Sausville, Susan G. Arbuck, Richard A. Messmann et al. · Journal of Clinical Oncology · 2001 · 294 citations

Synergistic Drug Combinations for Tuberculosis Therapy Identified by a Novel High-Throughput Screen

Santiago Ramón‐García, Carol Ng, Hilary Anderson et al. · Antimicrobial Agents and Chemotherapy · 2011 · 183 citations · Full text

Tuberculosis Therapy Identified, Pharmaceutical Research, Synergistic Drug Combinations +28

Yeast genome-wide drug-induced haploinsufficiency screen to determine drug mode of action

Kristin Baetz, Lianne M. McHardy, Ken Gable et al. · Proceedings of the National Academy of Sciences · 2004 · 175 citations · Full text

Systems Pharmacology, Therapeutic Action, Drug Repositioning +15

Structure-Activity Analysis of Niclosamide Reveals Potential Role for Cytoplasmic pH in Control of Mammalian Target of Rapamycin Complex 1 (mTORC1) Signaling

Bruno D. Fonseca, Graham H. Diering, Michael Bidinosti et al. · Journal of Biological Chemistry · 2012 · 160 citations · Full text